Innate Pharma SA IPHA 深 沪
等待开盘 03-26 09:30:00 美东时间
1.3199
+0.060
+4.75%
华盛通- 最 高1.3199
- 今 开1.29
- 成交量 3249股
- 最 低 1.29
- 昨 收 1.26
- 总市值 1.24亿
- 52周最高 2.63
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.17
- 委 比 93.61%
- 总股本 9372.47万
- 历史最高 11.95
- 量 比 0.16
- 振 幅 2.37%
- 历史最低 1.17
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
BTIG Assumes Innate Pharma at Buy, Announces Price Target of $8
BTIG analyst Jeet Mukherjee assumes Innate Pharma (NASDAQ:IPHA) with a Buy rating and announces Price Target of $8.
03-12 18:58
Innate Pharma to Join Leerink Partners Global Healthcare Conference in Miami
Innate Pharma to Join Leerink Partners Global Healthcare Conference in Miami Innate Pharma SA will participate in the Leerink Partners Global Healthcare Conference 2026, held in Miami, Florida, from March 8-11, 2026. The company’s executive team will join a fireside chat on March 9, 2026, at 3:40 PM
02-18 14:00
FDA Clears Innate Pharma to Begin Phase 3 Trial of Lacutamab in CTCL
Innate Pharma SA has announced that the U.S. Food and Drug Administration (FDA) has cleared the company to proceed with the TELLOMAK 3 confirmatory Phase 3 trial of lacutamab in cutaneous T-cell lymph...
2025-11-10 14:00
Innate Pharma Schedules Q3 2025 Results Conference Call
The latest announcement is out from Innate Pharma SA ( ($FR:IPH) ). On November...
2025-11-05 19:27
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
2025-10-30 14:22
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target
BTIG analyst Justin Zelin reiterates Innate Pharma (NASDAQ:IPHA) with a Buy and maintains $8 price target.
2025-10-29 17:34
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers SciSparc (NASDAQ:SPRC) stock increased by 40.8% to $6.28 during Tuesda...
2025-09-30 20:09
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
2025-09-19 09:18
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-09-18 22:00
